Copyright © 2021. Inderes Oyj. All rights reserved.
Käyttäjätili

Hei anonyymi!

Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.

Luo tili

Onko sinulla jo Inderes-tili?

Physitrack

Analyytikko

Sisäpiirin kaupat

Nettovaikuttavuus

Tiedotteet
7.11.
2022

Champion Health, part of the Physitrack Group, today announces the launch of another integrated care pathway into its premium Employee Wellbeing product – Mental Health Therapy. The new care pathway seamlessly integrates into Champion's user journey as of today and is expected to significantly accelerate the growth of its SaaS offering.

Tiedotteet
7.11.
2022

Another strong quarter, with top line growth of 72 per cent, significant EBITDA growth, and growing momentum in the Wellness segment

Tiedotteet
31.10.
2022

The global digital healthcare provider Physitrack PLC (PTRK) plans to publish its Q3 interim report 2022 on Monday November 7, at 08.00 CET. A webcast conference will take place at 10.00 CET.

Physitrack PLC's Q3 interim report 2022 will be published in English and available on https://www.physitrackgroup.com/investors/reports-presentations.

Tiedotteet
27.10.
2022

Champion Health, a leading workplace health platform and part of Physitrack PLC, today announces it has entered into a partnership with Currys PLC, the leading omnichannel retailer of technology products and services, to support and improve the wellbeing of Currys’ 15,000+ employees across the UK&I. Currys operates online and through 830 stores in 8 countries, and is the owner of Nordic brands Elkjøp, Elgiganten and Gigantti.

Tiedotteet
4.10.
2022

Physitrack PLC has adjusted its previously communicated financial calendar for 2022, where the date for publication of the Q3 interim report has been moved to 7 November 2022.

Updated financial calendar
7 November 2022 – Interim report Q3 (1 Jan 2022 – 30 Sep 2022) – new date
28 February 2023 – Year-end-report (1 Jan 2022 – 31 Dec 2022)

Tiedotteet
29.8.
2022

Henrik Molin, CEO and co-founder of Physitrack, has today acquired 700,000 shares in Physitrack from Nathan Skwortsow, co-founder of Physitrack, equivalent of 4.3% of the total share capital in the company. The private transaction boosts Henrik Molin’s ownership to 24.7% and reduces Nathan Skwortsow’s ownership to 17.8%.

The shares will be exchanged at a mutually agreed consideration of EUR 1 million in total, with the purpose to maintain control and succession.

Tiedotteet
26.8.
2022

Rachel King has acquired a total of 278,000 shares in Physitrack Plc in a private transaction with Physitrack’s co-founder and CEO Henrik Molin.

Rachel King is an accomplished Entrepreneur, Investor and the Widow of Dr John King, the CEO of previously LSE-listed Galen Pharmaceuticals and previously Nasdaq-listed Warner Chilcott.

Muut analyysit
26.8.
2022

Pro forma growth in line with company target Margin slightly pressured by virtual care acquisitionsTrading at 14 ‘23e EV/EBITDA Wellness segment showed strong pro forma growth The report was largely in line with our expectations when looking at sale

Muut analyysit
25.8.
2022

Q2: Limited deviations on sales and adj. EBITDASmall negative cons adj.

Tiedotteet
25.8.
2022

“A strong quarter, with revenue growth in-line with long-term targets and integration of the Wellness division”

Quarter ended – Apr - Jun 2022

Physitrack

ipo